A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy
TAK-079-1006
Phase 1 other active
Quick answer
A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy for IgAN is Primary Immunoglobulin A Nephropathy (IgAN) (also known as Berger's disease) is a Phase 1 program (other) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- IgAN is Primary Immunoglobulin A Nephropathy (IgAN) (also known as Berger's disease)
- Phase
- Phase 1
- Modality
- other
- Status
- active